HROW

Harrow, Inc.

17.10 USD
+0.34 (+2.03%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Harrow, Inc. stock is up 63.64% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 47.06% of the previous 17 May’s closed higher than April. In the last 10 Unusual Options Trades, there were 7 PUTs, 3 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
25 Apr 14:17 17 May, 2024 14.00 PUT 100 3070
26 Apr 17:45 17 May, 2024 14.00 PUT 300 3166
26 Apr 17:45 17 May, 2024 14.00 PUT 300 3166
03 May 17:31 18 Oct, 2024 6.00 CALL 100 0
13 May 15:05 18 Oct, 2024 15.00 CALL 497 10
14 May 19:51 18 Oct, 2024 16.00 PUT 200 169
15 May 13:48 21 Jun, 2024 16.00 PUT 404 972
15 May 18:58 18 Oct, 2024 15.00 CALL 500 508
16 May 14:42 18 Oct, 2024 20.00 PUT 205 16
17 May 15:29 17 Jan, 2025 20.00 PUT 78 2

About Harrow, Inc.

Harrow Health, Inc. owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases.